|
Title
|
|
|
|
Immune cells enhance selectivity of nanosecond-pulsed DBD plasma against tumor cells
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Cancer immunotherapy is a promising strategy that engages the patient's immune system to kill cancer cells selectively while sparing normal tissue. Treatment of macrophages with a nanosecond-pulsed dielectric barrier discharge directly enhanced their cytotoxic activity against tumor cells but not normal cells. These results underscore the clinical potential of plasma for cancer immunotherapy. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Plasma medicine
|
|
|
Publication
|
|
|
|
2017
|
|
|
Volume/pages
|
|
|
|
7
:1
(2017)
, p. 85-96
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|